TFF Pharmaceuticals Inc (NAS:TFFP)
$ 1.89 0.04 (2.16%) Market Cap: 5.86 Mil Enterprise Value: 2.62 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 30/100

Q2 2023 TFF Pharmaceuticals Inc Earnings Call Transcript

Aug 15, 2023 / 03:00PM GMT
Release Date Price: $10.25 (-8.89%)
Operator

Good morning, Ladies and gentlemen, and welcome to the TFF Pharmaceuticals Second Quarter 2023 Corporate Update and Earnings Conference Call. As a reminder, this conference is being recorded.

I will now turn the call over to your host, Corey Davis of LifeSci Advisors. You may begin your conference.

Corey George Davis
LifeSci Advisors, LLC - Relationship Manager

Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals Second Quarter 2023 Corporate Update and Earnings Conference Call. With me on the line this afternoon are Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals; Dr. Zamaneh Mikhak, Chief Medical Officer; and Kirk Coleman, Chief Financial Officer.

Before we get started, I would like to remind everyone that this call will contain forward-looking statements, including, without limitation, statements about the anticipated timing of achievement of clinical milestones, the potential to see positive effects in our Phase II studies, the number of treated patients necessary to make our decisions in regards to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot